Markets
About
Boreal is developing a new antibody discovery technology that involves breaking tolerance in vivo to generate broader antibody diversity against tough to immunize drug targets, like GPCRs and other transmembrane proteins.
Boreal is developing a new antibody discovery technology that involves breaking tolerance in vivo to generate broader antibody diversity against tough to immunize drug targets, like GPCRs and other transmembrane proteins.